Genetic diseases and molecular genetics
C. Legendre, D. Cohen, Y. Delmas, T. Feldkamp et autres
Introduction and Aims: Post-transplant aHUS recurrence leads to graft failure within 1 yr (year) in 60% of patients ( pts). 1 Case reports suggest that eculizumab (Ecu) rescues ongoing complement-mediated thrombotic microangiopathy (TMA) and prevents resulting graft loss in pts with post-transplant …
at, us, gb, fr, it, de, cy, se, ca (code pays fourni par la source)